Document ID: chunk:federal_register_of_legislation:F2024C01066:reg:7:p1
Version: federal_register_of_legislation:F2024C01066
Segment Type: reg
Provision Reference: reg 7 (pt 1/3)
Character Range: 16092–18987

7  Additional procedures for giving information
 (1) For the purposes of paragraphs 98AC(4)(b) and 99AAA(8)(a) of the Act, this section defines additional procedures to be followed by an approved supplier in giving information to the Chief Executive Medicare, on behalf of the Secretary, in relation to the supply by the approved supplier of pharmaceutical benefits, whether the information is given:
 (a) under subsection 98AC(1) of the Act; or
 (b) in making a claim under section 99AAA of the Act.

Claim made using manual system
 (2) Subsections (3) to (9) apply if the approved supplier's claim is made using the manual system.
 (3) The information must be accompanied by the prescriptions on the presentation of which the pharmaceutical benefits that are the subject of the claim were supplied.
 (4) On each prescription (other than an authority prescription, a repeat authorisation, a deferred supply authorisation or a prescriber bag supply form), there must be marked a stamp format in the area on the extreme left of the prescription, horizontally aligned with the pharmaceutical benefit to which it relates in such a way as to avoid obliterating any other information on the prescription.
Note: For prescription and repeat authorisation, see subsection 5(1).
 (5) On each prescription, there must be marked in the S section (or each S section) one or more serial numbers by the approved supplier, allotted in respect of each pharmaceutical benefit as follows:
 (a) in respect of general benefit prescriptions—commencing at "1" in each claim and continuing consecutively in respect of that claim;
 (b) in respect of concessional benefit prescriptions and concession card prescriptions—commencing at "C1" in each claim and continuing consecutively in respect of that claim;
 (c) in respect of entitlement card prescriptions—commencing at "E1" in each claim and continuing consecutively in respect of that claim;
 (d) in respect of prescriber bag supply forms—commencing at "1" in each claim and continuing consecutively in respect of that claim.
 (6) On each authority prescription, or repeat authorisation relating to an authority prescription, there must be marked as a prefix to the serial number allotted under subsection (5) the letter "A".
 (7) On each deferred supply authorisation, there must be marked as a prefix to the serial number allotted under subsection (5) the letter "D".
 (8) On each prescription (other than a prescription that was not in the possession of the approved supplier for reasons that are, in the opinion of the Chief Executive Medicare, outside the approved supplier's reasonable control), there must be marked in the A section (or each A section):
 (a) if an election by the approved supplier is in force under subsection 31(3) of the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020, and the prescription